Zobrazeno 1 - 10
of 107
pro vyhledávání: '"F. Kermeen"'
Publikováno v:
A15. TAKING PULMONARY REHABILITATION TO THE NEXT LEVEL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccffcbd5bed34172df3da58eeac6bba7
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1026
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1026
Autor:
Peter Hopkins, F. Kermeen, J. McCarthy, Marc Ziegenfuss, D. Mullany, Keith McNeil, John F. Fraser, John Dunning
Publikováno v:
The Journal of Heart and Lung Transplantation. 26:850-856
Background Ischemia–reperfusion injury (IRI) is a prominent cause of primary graft failure after lung transplantation and is associated with an altered surfactant profile. Experimental animal studies have found that replacement with exogenous surfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a12d7b7446d1bd2f07fe5181b78eab0
https://doi.org/10.1016/j.healun.2007.05.016
https://doi.org/10.1016/j.healun.2007.05.016
Autor:
G, Strange, M, Rose, F, Kermeen, C, O'Donnell, A, Keogh, E, Kotlyar, L, Grigg, A, Bullock, P, Disney, N, Dwyer, H, Whitford, D, Tanous, C, Frampton, R, Weintraub, D S, Celermajer
Publikováno v:
Internal medicine journal. 45(9)
The management of children with congenital heart disease (CHD) has improved over recent decades and several patients surviving with CHD into adulthood are increasing. In developed countries, there are now as many adults as there are children living w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22cf918448f5ae7e1501fd741a43294d
https://pubmed.ncbi.nlm.nih.gov/26011062
https://pubmed.ncbi.nlm.nih.gov/26011062
Autor:
R E, Harrison, J A, Flanagan, M, Sankelo, S A, Abdalla, J, Rowell, R D, Machado, C G, Elliott, I M, Robbins, H, Olschewski, V, McLaughlin, E, Gruenig, F, Kermeen, M, Halme, A, Räisänen-Sokolowski, T, Laitinen, N W, Morrell, R C, Trembath
Publikováno v:
Journal of Medical Genetics. 40:865-871
Background: Mutations of the transforming growth factor β (TGFβ) receptor components ENDOGLIN and ALK-1 cause the autosomal dominant vascular disorder hereditary haemorrhagic telangiectasia (HHT). Heterozygous mutations of the type II receptor BMPR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e61543a836714a0d089ad00ecd1456f7
https://doi.org/10.1136/jmg.40.12.865
https://doi.org/10.1136/jmg.40.12.865
Publikováno v:
Internal Medicine Journal. 41:366-368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b132bd3a7caa96513ea4a5942eac381
https://doi.org/10.1111/j.1445-5994.2011.02463.x
https://doi.org/10.1111/j.1445-5994.2011.02463.x
Publikováno v:
European Respiratory Journal. 12:301-308
Pulmonary surfactant abnormalities have consistently been documented in patients with acute lung injury (ALI), however, there is little evidence directly correlating them to altered respiratory mechanics. To explore this further, surfactant compositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48adc630666113de15cb569f8b7ea5cd
https://doi.org/10.1183/09031936.98.12020301
https://doi.org/10.1183/09031936.98.12020301
Autor:
K B, Morrisroe, W, Stevens, H, Nandurkar, D, Prior, V, Thakkar, J, Roddy, J, Zochling, J, Sahhar, K, Tymms, A, Sturgess, G, Major, F, Kermeen, C, Hill, J, Walker, P, Nash, E, Gabbay, P, Youssef, S M, Proudman, M, Nikpour
Publikováno v:
Clinical and experimental rheumatology. 32(6 Suppl 86)
To determine the prevalence and correlates of antiphospholipid antibodies (APLA) in systemic sclerosis (SSc).Nine hundred and forty SSc patients were tested for APLA using an ELISA assay at recruitment. Clinical manifestations were defined as present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d53a77e84891fe455a9f7b7fed40ddec
https://pubmed.ncbi.nlm.nih.gov/24564981
https://pubmed.ncbi.nlm.nih.gov/24564981
Publikováno v:
Internal medicine journal. 44(2)
On 5 May 2013 it was World Pulmonary Hypertension (PHT) Day marking three decades on from the first reported deaths in an epidemic because of toxic rapeseed (canola) oil. This epidemic provided the impetus to the first World Health Organization to se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::abd6bf97004018287eeb114932b3eeda
https://pubmed.ncbi.nlm.nih.gov/24383793
https://pubmed.ncbi.nlm.nih.gov/24383793
Autor:
B, Dalton, K, McNeil, A, Keogh, T, Williams, S, Proudman, E, Gabbay, E, Kotlyar, R, Weintraub, F, Kermeen, D, Celermajer, J, Boland
Publikováno v:
International journal of clinical practice. 66(11)
Pulmonary hypertension (PH) is a condition that affects more than 25 million individuals worldwide and causes premature disability and death. Despite advances in our understanding of this condition, education and training of health professionals has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::639dbe2a5c53d64a09155986e177887c
https://pubmed.ncbi.nlm.nih.gov/23067036
https://pubmed.ncbi.nlm.nih.gov/23067036
Autor:
A, Keogh, G, Strange, E, Kotlyar, T, Williams, D, Kilpatrick, P, Macdonald, K, Brown, A, Pidoux, F, Kermeen, P, Steele, B, Dalton, E, Gabbay
Publikováno v:
Internal medicine journal. 41(3)
Several cellular pathways are implicated in the pathogenesis of pulmonary arterial hypertension (PAH) and attempts to arrest disease progression with a single drug would not be expected to succeed in the medium term. In clinical practice, combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d80b5ab6abda83c6909ca42757e66d3
https://pubmed.ncbi.nlm.nih.gov/21118410
https://pubmed.ncbi.nlm.nih.gov/21118410